Ligand validation:4ECT

DPO: DIPHOSPHATE

DPO is a Ligand Of Interest in 4ECT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4ECT_DPO_P_505	99%	47%	0.051	0.984	0.8	1.23	-	1	0	0	100%	0.4
5KG0_DPO_A_507	100%	51%	0.039	0.99	0.77	1.12	-	1	0	0	100%	0.2
5KFJ_DPO_A_508	100%	52%	0.044	0.991	0.78	1.08	-	1	0	0	100%	0.4
5KFI_DPO_A_508	100%	54%	0.043	0.988	0.73	1.04	-	1	0	0	100%	0.4
5KFL_DPO_A_507	100%	52%	0.043	0.988	0.84	1.03	-	1	0	0	100%	0.6
5KG6_DPO_A_507	100%	46%	0.044	0.989	0.73	1.32	-	1	0	0	100%	10
4ECS_DPO_P_502	100%	45%	0.047	0.992	0.73	1.38	-	1	2	0	100%	15

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.